Florida hospital CEO manages from 'arm's length' as cancer diagnosis leaves her immunocompromised

Grisel Fernandez-Bravo, DNP, CEO of Memorial Hospital Miramar (Fla.), has had to find new ways to manage operations after treatment for her cancer diagnosis left her immunocompromised and susceptible to COVID-19.

In 2018, Dr. Fernandez-Bravo was diagnosed with smoldering multiple myeloma. She is enrolled in a clinical trial at the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at the Dana-Farber/Brigham and Women's Cancer Center in Boston. 

Dr. Fernandez-Bravo is used to commuting between Massachusetts and Florida for treatment, though now she drives instead of flying due to COVID-19. Because of her immunocompromised state, she has addressed supply concerns and worked on creating emergency evaluation tents at her hospital without being on-site.

Dr. Fernandez-Bravo, who describes herself as a hands-on leader, still answers around-the-clock phone calls and videoconferencing, managing her hospital from what she told Dana-Farber Cancer Institute is "an arm's length." 

"I'm lucky because I have an amazing team who can be the boots on the ground for me," Dr. Fernandez-Bravo said. "It's been difficult to be away, but I am grateful I can continue to work, even if it's at an arm's length."

Read the full article from the Dana-Farber Cancer Institute here.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

 

Already Registered? Click here to confirm.